Antibacterial efficacy of lytic bacteriophages against antibiotic-resistant Klebsiella species

TheScientificWorldJournal

Volumn 11, Issue , 2011, Pages 1332-1340

  Khajeh Karamoddini, M ^a   Fazli Bazzaz, B S ^b   Emamipour, F ^a   Sabouri Ghannad, M ^c   Jahanshahi, A R ^a   Saed, N ^a   Sahebkar, A ^b,d  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antibiotic resistance; Bacteriophage; Klebsiella

Indexed keywords

AGAR; PROBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIOPHAGE; BACTERIUM ISOLATION; CONCENTRATION (PARAMETERS); DRUG EFFICACY; INCUBATION TEMPERATURE; KLEBSIELLA; LIQUID CULTURE; NONHUMAN; PREVALENCE; SEPTIC TANK; VIRUS ISOLATION; WASTE WATER;

ANTI-BACTERIAL AGENTS; BACTERIOPHAGES; DRUG RESISTANCE, BACTERIAL; KLEBSIELLA; MICROBIAL SENSITIVITY TESTS; VIRUS CULTIVATION;

BACTERIA (MICROORGANISMS); EUKARYOTA; KLEBSIELLA;

EID: 79960498815     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2011.114     Document Type: Article

References (36)

1. McNerney, R. and Traore, H. (2005) Mycobacteriophage and their application to disease control. J. Appl. Microbiol. 99, 223-233.
2. Ackermann, H.W. (2003) Bacteriophage observations and evolution. Res. Microbiol. 154, 245-251.
3. Higgins, S.E., Higgins, J.P., Bielke, L.R., and Hargis, B.M. (2007) Selection and application of bacteriophages for treating Salmonella enteritidis infections in poultry. Int. J. Poult. Sci. 6, 163-168.
4. Levin. B.R. and Bull, J.J. (1996) Phage therapy revisited: the population biology of a bacterial infection and its treatment with bacteriophage and antibiotics. Am. Naturalist 146, 881-898.
5. Markoishvili, K., Djavakhishvili, N., Goderdzishvili, M., Meipariani, A., Chavchanidze, Z., Tsitlanadze, G., and Katsarava, R. (1999) Phagebioderm - new prospects for treatment of wounds and trophic ulcers. Exp. Clin. Med. 2, 83-84.
6. Saunders, M.E. (1994) Bacteriophages in industrial fermentations. In Encyclopedia of Virology. Webster, R. and Cranoff, A., Eds. Academic Press, London. pp. 116-121.
7. Bradbury, J. (2004) My enemy's enemy is my friend. Lancet 363, 624-625.
8. Levin, B.R. and Bull, J.J. (2004) Population and evolutionary dynamics of phage therapy. Nat. Rev. Microbiol. 2, 166-173.
9. Inal, J.M. (2003) Phage therapy: a reappraisal of bacteriophages as antibiotics. Arch. Immunol. Ther. Exp. 51, 237-244.
10. Stone, R. (2002). Bacteriophage therapy: Stalin's forgotten cure. Science 298, 728-731.
11. Sulakvelidze, A., Alavidze, Z., and Morris, J.G. (2001) Bacteriophage therapy. Antimicrob. Agents Chemother. 45, 649-659.
12. Weber-Dabrowska, B., Mulczyk, M., and Gorski, A. (2000) Bacteriophage therapy of bacterial infections: an update of our Institute's experience. Arch. Immunol. Ther. Exp. 48, 547-551.
13. Balow, A. and Duerden, B.I. (1998) Topley and Wilsons Microbiology and Microbial Infections. 9th ed. Vol. 2. Arnold, London. pp. 166-286.
14. Cairns, J., Stent, G., and Watson, J. (1996) Phage and the Origins of Molecular Biology. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
15. Lederberg, J. (1996) Smaller fleas ... ad infinitum: therapeutic bacteriophage redux. Proc. Natl. Acad. Sci. U. S. A. 93, 3167-3168.
16. Proctor, L.M. and Fuhrman, J.A. (1990) Viral mortality of marine bacteria and cyanobacteria. Nature 343, 60-62.
17. Kutter, E., Gachechiladze, K., Poglazov, A., Marusich, E., Shneider, M., Aronsson, P., Napuli, A., Porter, D., and Mesyanzhinov, V. (1996) Evolution of T4 related phages. Virus Genes 11, 285-297.
18. Radetsky, P. (1996) Return of the good virus. Discover 17, 50-58.
19. Krueger, A.P. and Northrop, J.H. (1931) The kinetics of the bacterium - bacteriophage reaction. J. Gen. Physiol. 14, 223.
20. Payne, R.J.H. and Jansen, V.A.A. (2000) Phage therapy, the peculiar kinetics of self-replicating pharmaeuticals. Clin. Pharmacol. Ther. 68, 225-230.
21. Stencel, Ch. (1999) Phages eyed as agents to protect against harmful E. coli. A.S.M. News 65, 666-667.
22. Thomas, A., Lalitha, M.K., Jesudason, M.V. and John, S. (1983) Activity of bacteriophages. Am. Arch. Med. 25, 211-214.
23. Cairns, B.J. and Payne, R.J. (2008) Bacteriophage therapy and the mutant selection window. Antimicrob. Agents Chemother. 52, 4344-4350.
24. Mankiewicz, E., Kurth, V., and Adomonis, H. (1974) The effect of bacteriophages particles on cell-mediated immune reactions. Can. J. Microbiol. 20, 1209-1218.
25. Wenger, S.L., Turner, J.H., and Petricciani, J.C. (1978) The cytogenetic, proliferative and viability effects of four bacteriophages on human lymphocytes. In Vitro 14, 543-549. (Pubitemid 8377214)
26. Zimecki, M., Weber-Dabrowska, B., Lusiak-Szelachowska, M., Mulczyk, M., Boratynski, J., Pozniak, G., Syper, D., and Gorski, A. (2003) Bacteriophages provide regulatory signals in mitogen-induced murine splenocyte proliferation. Cell. Mol. Biol. Lett. 8, 699-711.
27. Kniotek, M., Ahmed, A.M.A., Dabrowska, K., Switala-Jelen, K., Opolski, A., and Gorski, A. (2004) Bacteriophage interactions with T cells and platelets. In Cytokine Network, Regulatory Cells, Signalling, and Apoptosis (Immunology 2004). Medimont, Bologna, Monduzzi Editore International Proceedings Division. pp. 189-193.
28. Dabrowska, K., Opolski, A., Wietrzyk, J., Switala-Jelen, K., Godlewska, J., Boratynski, J., Syper, D., Weber-Dabrowska, B., and Gorski, A. (2004) Anticancer activity of bacteriophage T4 and its mutant HAP1 in mouse experimental tumor models. Anticancer Res. 24, 3991-3995. (Pubitemid 40468698)
29. Joerger, R.D. (2003) Alternatives to antibiotics: bacteriocins, antimicrobial peptides and bacteriophages. Poult. Sci. 82, 640-647.
30. Sechter, I., Mestre, F., and Hansen, D.S. (2000) Twenty-three years of Klebsiella phage typing: a review of phage typing of 12 clusters of nosocomial infections, and a comparison of phage typing with K serotyping. Clin. Microbiol. Infect. 6, 233-238.
31. Weld, R.J., Butts, C., and Heinemann, J.A. (2004) Models of phage growth and their applicability to phage therapy. J. Theor. Biol. 227, 1-11.
32. Sulakvelidze, A., Alavidze, Z., and Glenn Morris, J., Jr. (2001) Bacteriophage therapy. Antimicrob. Agents Chemother. 45, 649-659.
33. Skurnik, M. and Strauch, E. (2006) Phage therapy: facts and fiction. Int. J. Med. Microbiol. 296, 5-14.
34. Labrie, S.J., Samson, J.E., and Moineau, S. (2010) Bacteriophage resistance mechanisms. Nat. Rev. Microbiol. 8, 317-327.
35. Hayashi, M. (1988) Biology of the bacteriophage QX174. In The Bactriophages. Calendar, R., Ed. Plenum, New York.
36. Spencer, R.C. (1996) Predominant pathogens found in the European prevalence of infection in intensive care study. Eur. J. Clin. Microbiol. Infect. Dis. 15, 281-285.